Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Ongoing Initiated Nov 13, 2023 (3 years ago)

Up&Up brand dry eye relief

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Non-Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Up&Up brand dry eye relief (Carboxymethylcellulose 0.5%) packaged in 0.5 FL OZ (15 mL) each bottles (Twin Pack), Distributed by: Target Corporation Minneapolis, MN 55403, NDC 76168-800-30

Affected NDC 76168-0800-30

Compare with the code on your package — it is the most precise check available.

Recalling firm
Kilitch Healthcare India Limited
NDC code
76168-800-30
Origin
India
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0311-2024 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week.

Other recalls by Kilitch Healthcare India Limited

All 2023 recalls

Other sterility / contamination recalls from 2023

All sterility / contamination recalls